GXI.DE Gerresheimer AG XETRA -17% intraday 26 Feb 2026: earnings will matter
GXI.DE stock fell to €15.42 on XETRA today, down -17.27% or -€3.22 intraday as markets price ahead of the company earnings release on 26 Feb 2026. Traders pushed volume to 951,174 shares versus a 50-day average near 287,940, signalling a sharp reaction to the results risk. We summarise the Q4 earnings setup, key ratios like PE 27.10 and EPS €0.68, and what investors should watch when the Gerresheimer AG report hits after the close.
Earnings preview: GXI.DE stock and Q4 timing
Gerresheimer announces results on 26 Feb 2026 after market close; the earnings call is scheduled for 16:30 UTC. Traders are focused on revenue guidance and margin drivers in Plastics & Devices and Primary Packaging Glass. One near-term claim: weak guidance could force another leg lower given high net debt and tight cash conversion metrics.
Market reaction and intraday price action for GXI.DE stock
Shares opened at €15.51, traded between €14.83 and €16.15, and closed intraday near €15.42 on heavy turnover. Volume of 951,174 equals about 3.31x the average daily volume, indicating distribution. The same-day drop of -€3.22 connects directly to sentiment ahead of the print and the wider healthcare sector softness in Germany today.
Fundamentals and valuation snapshot
Gerresheimer AG reports market cap €636,572,200.00, EPS €0.68, and trailing PE 27.10. Book value per share stands at €41.34, while price-to-book is 0.45, reflecting market de-rating versus balance sheet strength. Net debt metrics show enterprise value €2,801,270,200.00 and netDebt/EBITDA 5.48, highlighting leverage as a primary valuation risk.
Technical and volume snapshot for GXI.DE stock
Technicals show RSI 30.85, MACD negative and ADX 33.44 for a strong downtrend. Bollinger lower band sits at €16.17, below today’s close, and ATR is €1.37, indicating elevated volatility. High relative volume and negative on-balance volume confirm sellers dominated today, increasing the chance of follow-through before the earnings release.
Meyka AI rates GXI.DE with a score out of 100 and forecast
Meyka AI rates GXI.DE with a score out of 100: 66.44 (Grade B, Suggestion: HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects monthly €11.28 and quarterly €14.81, implying a -26.86% and -3.99% move versus the current price €15.42 respectively. Forecasts are model-based projections and not guarantees.
Risks, opportunities and analyst view
Key risks include high leverage with debt-to-equity 1.65, weak free cash flow per share -€2.51, and margin pressure in primary glass. Opportunities include product mix recovery in Advanced Technologies and pricing power in drug-delivery systems. Market consensus ratings are mixed; third-party scorecards showed a company rating of C+ on 24 Feb 2026 with a Sell bias, underlining divergent views.
Final Thoughts
Takeaways: GXI.DE stock trades at €15.42 after a -17.27% intraday move as investors position ahead of Gerresheimer AG’s earnings on 26 Feb 2026. The company shows solid book value €41.34 per share but carries elevated leverage and negative free cash flow per share -€2.51. Meyka AI’s forecast model projects €11.28 (monthly) and €14.81 (quarterly), implying -26.86% and -3.99% relative to today. For scenario planning we set price targets: conservative €12.00 (downside -22.18%), base €18.00 (upside +16.74%), bull €28.00 (upside +81.58%). These targets reflect balance-sheet risk, near-term earnings sensitivity, and optionality from advanced drug-delivery products. Use the earnings print and management guidance to re-weight risk; Meyka AI, an AI-powered market analysis platform, will update forecasts after the release. Forecasts are model-based projections and not guarantees.
FAQs
When does Gerresheimer report earnings and how does it affect GXI.DE stock?
Gerresheimer reports on 26 Feb 2026 after the close; results and guidance will likely drive intraday volatility in GXI.DE stock, as seen in the current volume surge and a 17% intraday drop.
What are the key financial risks to watch in the GXI.DE analysis?
Main risks are high net debt with netDebt/EBITDA 5.48, free cash flow per share -€2.51, and tight interest coverage 1.64, all of which feature prominently in GXI.DE stock analysis ahead of earnings.
How should investors use the Meyka AI forecast for GXI.DE stock?
Meyka AI’s model shows monthly €11.28 and quarterly €14.81; use these as scenario inputs, not certainties, and compare them to company guidance and the earnings press release before adjusting GXI.DE stock positions.
What technical signals matter for short-term GXI.DE stock trading?
Short-term traders should watch RSI 30.85 (near oversold), MACD negative, ADX 33.44 for trend strength, and today’s volume 951,174, all indicating potential follow-through risk for GXI.DE stock.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.